PharmAlliance Announces Acquisition of CHEORS
With this addition, PharmAlliance strengthens its global reach and expands its launch and commercialization capabilities.
- With this addition, PharmAlliance strengthens its global reach and expands its launch and commercialization capabilities.
- View the full release here: https://www.businesswire.com/news/home/20240416800738/en/
CHEORS marks the third strategic acquisition for PharmAlliance, a portfolio company of Waud Capital Partners . - “CHEORS’ excellent reputation and unique approach is an important next step in the expansion of the PharmAlliance portfolio,” said Mark Bouck, Chairman & CEO of PharmAlliance and BioBridges.
- "From the outset, the synergies between CHEORS and PharmAlliance have been very attractive.